Your browser doesn't support javascript.
loading
Speed of cooling after cardiac arrest in relation to the intervention effect: a sub-study from the TTM2-trial.
Simpson, Rupert F G; Dankiewicz, Josef; Karamasis, Grigoris V; Pelosi, Paolo; Haenggi, Matthias; Young, Paul J; Jakobsen, Janus Christian; Bannard-Smith, Jonathan; Wendel-Garcia, Pedro D; Taccone, Fabio Silvio; Nordberg, Per; Wise, Matt P; Grejs, Anders M; Lilja, Gisela; Olsen, Roy Bjørkholt; Cariou, Alain; Lascarrou, Jean Baptiste; Saxena, Manoj; Hovdenes, Jan; Thomas, Matthew; Friberg, Hans; Davies, John R; Nielsen, Niklas; Keeble, Thomas R.
Affiliation
  • Simpson RFG; Essex Cardiothoracic Centre, MSE Trust, Basildon, Essex, UK.
  • Dankiewicz J; MTRC, Anglia Ruskin School of Medicine, Chelmsford, Essex, UK.
  • Karamasis GV; Department of Clinical Sciences Lund, Sections of Cardiology, Lund, Sweden.
  • Pelosi P; Essex Cardiothoracic Centre, MSE Trust, Basildon, Essex, UK.
  • Haenggi M; MTRC, Anglia Ruskin School of Medicine, Chelmsford, Essex, UK.
  • Young PJ; Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.
  • Jakobsen JC; Anesthesiology and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy.
  • Bannard-Smith J; Department of Intensive Care Medicine, University Hospital Bern, University of Bern, Bern, Switzerland.
  • Wendel-Garcia PD; Intensive Care Unit, Wellington Hospital, Wellington, New Zealand.
  • Taccone FS; Medical Research Institute of New Zealand, Wellington, New Zealand.
  • Nordberg P; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.
  • Wise MP; Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia.
  • Grejs AM; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Capital Region of Denmark, Denmark.
  • Lilja G; Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Copenhagen, Denmark.
  • Olsen RB; Department of Adult Critical Care, Manchester University NHS Foundation Trust, Manchester, UK.
  • Cariou A; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, UK.
  • Lascarrou JB; Institute of Intensive Care Medicine, University Hospital of Zurich, Zurich, Switzerland.
  • Saxena M; Department of Intensive Care, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Hovdenes J; Department of Clinical Science and Education, Center for Resuscitation Science, Karolinska Institute, Solna, Sweden.
  • Thomas M; Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
  • Friberg H; Adult Critical Care, University Hospital of Wales, Cardiff, UK.
  • Davies JR; Department of Intensive Care Medicine, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Nielsen N; Neurology, Department of Clinical Sciences Lund, Skane University Hospital, Lund University, Lund, Sweden.
  • Keeble TR; Department of Anesthesiology, Sørlandet Hospital, Arendal, Norway.
Crit Care ; 26(1): 356, 2022 11 15.
Article in En | MEDLINE | ID: mdl-36380332
ABSTRACT

BACKGROUND:

Targeted temperature management (TTM) is recommended following cardiac arrest; however, time to target temperature varies in clinical practice. We hypothesised the effects of a target temperature of 33 °C when compared to normothermia would differ based on average time to hypothermia and those patients achieving hypothermia fastest would have more favorable outcomes.

METHODS:

In this post-hoc analysis of the TTM-2 trial, patients after out of hospital cardiac arrest were randomized to targeted hypothermia (33 °C), followed by controlled re-warming, or normothermia with early treatment of fever (body temperature, ≥ 37.8 °C). The average temperature at 4 h (240 min) after return of spontaneous circulation (ROSC) was calculated for participating sites. Primary outcome was death from any cause at 6 months. Secondary outcome was poor functional outcome at 6 months (score of 4-6 on modified Rankin scale).

RESULTS:

A total of 1592 participants were evaluated for the primary outcome. We found no evidence of heterogeneity of intervention effect based on the average time to target temperature on mortality (p = 0.17). Of patients allocated to hypothermia at the fastest sites, 71 of 145 (49%) had died compared to 68 of 148 (46%) of the normothermia group (relative risk with hypothermia, 1.07; 95% confidence interval 0.84-1.36). Poor functional outcome was reported in 74/144 (51%) patients in the hypothermia group, and 75/147 (51%) patients in the normothermia group (relative risk with hypothermia 1.01 (95% CI 0.80-1.26).

CONCLUSIONS:

Using a hospital's average time to hypothermia did not significantly alter the effect of TTM of 33 °C compared to normothermia and early treatment of fever.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiopulmonary Resuscitation / Out-of-Hospital Cardiac Arrest / Hypothermia / Hypothermia, Induced Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Crit Care Year: 2022 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiopulmonary Resuscitation / Out-of-Hospital Cardiac Arrest / Hypothermia / Hypothermia, Induced Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Crit Care Year: 2022 Document type: Article Affiliation country: Reino Unido
...